{"nctId":"NCT02320825","briefTitle":"Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases","startDateStruct":{"date":"2014-12-16","type":"ACTUAL"},"conditions":["Spinal Metastases"],"count":16,"armGroups":[{"label":"single-fraction SRS (24 Gy)","type":"EXPERIMENTAL","interventionNames":["Radiation: single-fraction SRS","Behavioral: Quality of Life Measures"]},{"label":"high-dose hypofractionated SRS (27 Gy in 3 fractions)","type":"EXPERIMENTAL","interventionNames":["Radiation: high-dose hypofractionated SRS","Behavioral: Quality of Life Measures"]}],"interventions":[{"name":"single-fraction SRS","otherNames":[]},{"name":"high-dose hypofractionated SRS","otherNames":[]},{"name":"Quality of Life Measures","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Histologically diagnosed metastatic cancer (Diagnosis made or confirmed at MSKCC for MSKCC participants. Institutional pathologic determination accepted from participating multicenter sites.)\n* Age ≥18 years\n* Life expectancy ≥3 months\n* ECOG ≤ 3\n* Spinal surgery carried out with the goal of spinal cord decompression and spinal stabilization within 8 weeks\n* Post-operative CT myelogram or MRI perfusion with evidence of separation of tumor and the spinal cord It should be noted that patients with multiple lesions will be eligible as long as there are no overlapping fields of radiation, including at various time frames.\n\nExclusion Criteria:\n\n* Primary spine tumor\n* Age \\< 18\n* Pregnancy\n* Lack of adequate (≥ 2 mm) separation between the spinal cord and the tumor on post-operative CT myelogram or MRI perfusion\n* Radiosensitizing chemotherapy (taxol, taxotere, cisplatin, gemcitabine, 5-fluorouracil) given within one week of radiation treatment","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Local Tumor Control Using MRI or CT","description":"will be radiographically determined according to routine standard of care post-surgical and post-treatment imaging (MRI or CT) of the spine. Local tumor control will be defined as the lack of local tumor progression at the irradiated site on follow-up imaging.","paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Treatment-related Toxicity Using CTCAE v4.0","description":"Adverse events will be assessed by the investigators according to the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 4.0","paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Quality of Life Between the Two Cohorts Determined Through Patient-reported Responses of the BPI","description":"will be determined through patient-reported responses of the BPI. Pain severity at its worst (question #5) and the average of the pain interference (average of question #9)","paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":8},"commonTop":[]}}}